EffectIV™ Cap

Making IV Risks More Manageable

EffectIV Product Photo 248x200

Our EffectIV™ cap creates a physical barrier against external contamination and wear. The sterile, non-DEHP threaded cap is designed for single-use and natural rubber latex has not been used in the manufacture of the device. Its unique shape fits needleless injection ports and other IV access points.

The EffectIV cap contains a sponge saturated with 70 percent isopropyl alcohol — a standard disinfectant solution — and is packaged for clinician portability and convenience.

Key Benefits:

  • Effectively disinfects a luer-activated valve injection port when left in place for 5 to 10 minutes1
  • Provides a physical barrier protecting the port from external contamination and routine wear for up to 96 hours1
  • A secured EffectIV cap provides visual confirmation that can help support hospital infection control practices

For more information on the EffectIV cap, contact your Hospira sales representative or call us
at 1-877-946-7747.

This page is intended to serve as notice under 35 U.S.C. § 287(a) for patents: 8,740,864; 7,780,794; 7,985,302; 8,206,514; and 8,999,073.

  1. Data on file. Hospira, Inc.